Social Capital Suvretta Holdings Corp. III

Status: Deal Closed
U=S
IPO Proceeds, $M $250.00M
IPO Date Jun 30, 2021
CEO Chamath Palihapitiya
Left Lead Morgan Stanley
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Biotechnology industry and within the organ space subsector

IPO Geography Global
Target Company ProKidney
Deal Announced Jan 18, 2022
Deal Size, $M $1,835.00M
Deal Sector Healthcare
Deal Geography Global
SEC Filings www.sec.gov
Approval Vote Jul 11, 2022
Amendment Vote TBD
Closing Date Jul 11, 2022
Formerly DNAC PROK

Sign up for Free Trial

No credit card required

Sign in for more on Social Capital Suvretta Holdings Corp. III:

  • Structure and cap table
  • 6 directors & officers
  • 22 filings and events
  • 2 underwriters
  • 7 deal advisors
  • 6 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Chamath Palihapitiya 44 Chief Executive Officer and Chairman of the Board of Directors
Kishan (a/k/a Kishen) Mehta 35 President and Director
James Ryans 45 Chief Financial Officer
Shoney Katz 46 Director of Research
Marc Semigran 64 Director
Uma Sinha PhD Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Morgan Stanley BR 19,800,000 units
SoFi 2,200,000
22,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 22 filings.

Shareholders

Sign in to view shareholders 13F filing data.